NEW YORK, May 9 – Discovery Partners International has completed its acquisition of  gene profiling technology company Xenometrix, the company said Wednesday.

Xenometrix of Boulder, Colo., is the latest addition to Discovery Partners’ drug discovery technology offerings. In February, Discovery Partners signed the initial agreement to acquire Xenometrix for $1.7 million. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.